Surgery · Endocrinology · 2 h ago
MBSAQIP analysis compares six-month outcomes after ESG and sleeve gastrectomy
A retrospective analysis of 115,476 procedures in the 2023 MBSAQIP database compared six-month outcomes after endoscopic sleeve gastroplasty (ESG) and laparoscopic sleeve gastrectomy (LSG). LSG was associated with greater weight loss and more improvement in metabolic comorbidities, although the ESG group was much smaller and had lower baseline BMI.
- LSG was associated with greater six-month weight loss.
- The ESG group included 509 patients; LSG included 114,967.
- Baseline BMI was lower in the ESG group.
- Comparative safety results were not provided in the abstract.
Researchers used 2023 data from accredited MBSAQIP centers, linked to six-month follow-up, to compare elective ESG with LSG. The analysis included 114,967 LSG procedures and 509 ESG procedures. Outcomes included weight and metabolic comorbidity changes, as well as serious complications and emergency department readmissions; the abstract provided no comparative results for the latter two outcomes.
At six months, mean BMI loss was 8.2 kg/m² after LSG and 3.9 kg/m² after ESG; mean total weight loss was 22.6 kg and 11.1 kg, respectively. The authors reported improvements in diabetes medication or insulin dependence, dyslipidemia, hypertension, and sleep apnea after LSG, but no clinically meaningful comorbidity improvement after ESG. ESG patients had lower baseline BMI (40.9 vs 45.0 kg/m²) and body weight, and were slightly older.
These observational findings describe outcomes in routine accredited-center practice, but the marked group-size imbalance and baseline differences limit direct comparisons. The six-month follow-up does not establish long-term durability, and the results do not by themselves determine which procedure is appropriate for an individual patient.
In practice
For adults undergoing bariatric procedures at accredited centers, this database analysis found greater six-month weight loss after LSG than after ESG, alongside reported metabolic comorbidity improvements after LSG but not ESG. These findings may inform discussions of observed outcomes, but they do not establish that one procedure is preferable for an individual patient. The comparison was observational, ESG numbers were small relative to LSG, baseline BMI and weight differed, and follow-up was limited to six months; long-term comparative durability remains uncertain.
AI-generated clinical interpretation · Not editor-reviewed
Is this summary clinically accurate?
Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.
Sign in to rate this summary →Source
Surgical Endoscopy: Six-month comparative outcomes of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy: an MBSAQIP analysis ↗This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.